A novel blood-based assay could transform coeliac disease diagnosis, particularly for patients already on a gluten-free diet.

BridgeBio Pharma, Inc. (NASDAQ: BBIO ), ein biopharmazeutisches Unternehmen in der klinischen Phase mit einer Bewertung von 7 ...

Amyloidose – Diagnostik und Therapie einer unterdiagnostizierten Erkrankung Amyloidosis—the diagnosis and treatment of an underdiagnosed disease ...

Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University observe and model how the enzyme ADAR1 interacts with double-stranded RNA, which may be useful for future cancer ...

Wer aus Angst vor Symptomen auf Gluten verzichtet, macht eine Zöliakie-Diagnose oft unmöglich. Ein neues Verfahren soll das ...

Correction for “A twist grain boundary phase in aqueous solutions of the nucleic acid tetramer GTAC,” by Gregory P. Smith, Chenhui Zhu, Mikail Zernenkov, Guillaume Frechet, and Noel A. Clark, which ...

The tetramer showed an important decrease in activity, indicating that preactivation of the guide strands is necessary for optimal activity when working with the passenger strands connected through ...

Cardiac troponin T (cTnT) is a myofibrillar protein essential for calcium-dependent contraction. This property has led to functional studies of developmentally expressed cTnT isoforms and mutants ...

The whole blood IL-2 release assay provides a reliable, less invasive alternative for celiac disease diagnosis, showing high ...

Exploratory qualitative analyses of the neoantigen-specific T cell response by ELISpot were presented previously. In-depth characterization of the neoantigen-specific T cells including clonal ...